The price of Windtree Therapeutics Inc (NASDAQ:WINT) shares last traded on Wall Street rose 6.91% to $3.17.
WINT stock price is now -53.90% away from the 50-day moving average and -56.82% away from the 200-day moving average. The market capitalization of the company currently stands at $1.62M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $12.25, Ladenburg Thalmann recently initiated with Buy rating for Windtree Therapeutics Inc (NASDAQ: WINT).
In other news, Fraser Craig, President and CEO bought 2,500 shares of the company’s stock on Sep 27 ’23. The stock was bought for $2,550 at an average price of $1.02. Upon completion of the transaction, the President and CEO now directly owns 57,877 shares in the company, valued at $0.18 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 26 ’23, President and CEO Fraser Craig bought 2,500 shares of the business’s stock. A total of $2,250 was incurred on buying the stock at an average price of $0.90. This leaves the insider owning 55,377 shares of the company worth $0.18 million. A total of 13.38% of the company’s stock is owned by insiders.
During the past 12 months, Windtree Therapeutics Inc has had a low of $2.75 and a high of $27.00. As of last week, the company has a debt-to-equity ratio of 0.37, a current ratio of 0.23, and a quick ratio of 0.23. The fifty day moving average price for WINT is $6.876 and a two-hundred day moving average price translates $7.27565 for the stock.
The latest earnings results from Windtree Therapeutics Inc (NASDAQ: WINT) was released for 2024-06-30. The company reported revenue of $11.45 million for the quarter, compared to $6.76 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 69.48 percent.
